Skip to content
Clinical Trials – home
Assistance Publique Hopitaux De Marseille
Sponsor

Assistance Publique Hopitaux De Marseille

France 80 Rue Brochier, 13005 Marseille, France

About the sponsor

Clinical research includes acute kidney injury and septic shock, with interest in renal recovery, organ failure, and critical care support in unstable patients.

  • Acute kidney injury
  • Septic shock
  • chronically occluded coronary artery

Cardiovascular and kidney-related studies also address antiplatelet treatment after coronary intervention and monitoring of cardiac function during immune checkpoint inhibitor therapy.

About Specializations

Assistance Publique Hopitaux De Marseille runs clinical trials in conditions such as Crohn's disease, Neoplasm malignant, Septic shock, Gastrointestinal stromal tumour, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

23 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
  • Sponsor:Assistance Publique Hopitaux De Marseille

Septic shock

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib Mesilate
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Riluzole
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Microfat
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Autologous Cord Blood-Derived Mononuclear Cells
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Assistance Publique Hopitaux De Marseille
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Axitinib
  • Sponsor:Assistance Publique Hopitaux De Marseille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Clopidogrel
  • Sponsor:Assistance Publique Hopitaux De Marseille
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid
  • Sponsor:Assistance Publique Hopitaux De Marseille

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).